Treatment of Atypical Hemolytic-Uremic Syndrome in the Era of Eculizumab

Hemolytic-uremic syndrome (HUS) is the triad of microangiopathic hemolytic anemia (MAHA), thrombocytopenia, and acute kidney injury (AKI); the main cause of multi-organ failure is related to thrombotic microangiopathy (TMA). Atypical HUS (aHUS) is a disease of uncontrolled complement activation asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebrahem, Rawaa, Kadhem, Salam, Truong, Quoc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400517/
https://www.ncbi.nlm.nih.gov/pubmed/28439485
http://dx.doi.org/10.7759/cureus.1111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400517/
https://www.ncbi.nlm.nih.gov/pubmed/28439485
http://dx.doi.org/10.7759/cureus.1111

Ejemplares similares